131 related articles for article (PubMed ID: 8615657)
21. In vitro sequence-dependent interaction between nedaplatin and paclitaxel in human cancer cell lines.
Tanaka R; Takii Y; Shibata Y; Ariyama H; Qin B; Baba E; Kusaba H; Mitsugi K; Harada M; Nakano S
Cancer Chemother Pharmacol; 2005 Sep; 56(3):279-85. PubMed ID: 15875187
[TBL] [Abstract][Full Text] [Related]
22. In vitro concurrent paclitaxel and radiation of four vulvar squamous cell carcinoma cell lines.
Jaakkola M; Rantanen V; Grénman S; Kulmala J; Grénman R
Cancer; 1996 May; 77(9):1940-6. PubMed ID: 8646696
[TBL] [Abstract][Full Text] [Related]
23. S100P sensitizes ovarian cancer cells to carboplatin and paclitaxel in vitro.
Wang Q; He Z; Gao J; Hu S; Huang M; Liu M; Zheng J; Tang H
Cancer Lett; 2008 Dec; 272(2):277-84. PubMed ID: 18762368
[TBL] [Abstract][Full Text] [Related]
24. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
[TBL] [Abstract][Full Text] [Related]
25. Comparative evaluation of cisplatin and carboplatin sensitivity in endometrial adenocarcinoma cell lines.
Rantanen V; Grénman S; Kulmala J; Grénman R
Br J Cancer; 1994 Mar; 69(3):482-6. PubMed ID: 8123477
[TBL] [Abstract][Full Text] [Related]
26. Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy.
Keshelava N; Seeger RC; Groshen S; Reynolds CP
Cancer Res; 1998 Dec; 58(23):5396-405. PubMed ID: 9850071
[TBL] [Abstract][Full Text] [Related]
27. [Significance of formation of micronuclei in SCC VII murine cells treated with various chemotherapeutic agents].
Jeremić B; Sibamoto J; Abe M
Srp Arh Celok Lek; 1996; 124(7-8):169-74. PubMed ID: 9102841
[TBL] [Abstract][Full Text] [Related]
28. Clusterin confers paclitaxel resistance in cervical cancer.
Park DC; Yeo SG; Shin EY; Mok SC; Kim DH
Gynecol Oncol; 2006 Dec; 103(3):996-1000. PubMed ID: 16890274
[TBL] [Abstract][Full Text] [Related]
29. A potential synergistic anticancer effect of paclitaxel and amifostine on endometrial cancer.
Dai D; Holmes AM; Nguyen T; Davies S; Theele DP; Verschraegen C; Leslie KK
Cancer Res; 2005 Oct; 65(20):9517-24. PubMed ID: 16230417
[TBL] [Abstract][Full Text] [Related]
30. GRP78 induced by estrogen plays a role in the chemosensitivity of endometrial cancer.
Luvsandagva B; Nakamura K; Kitahara Y; Aoki H; Murata T; Ikeda S; Minegishi T
Gynecol Oncol; 2012 Jul; 126(1):132-9. PubMed ID: 22543280
[TBL] [Abstract][Full Text] [Related]
31. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
Brenes O; Arce F; Gätjens-Boniche O; Díaz C
Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942
[TBL] [Abstract][Full Text] [Related]
32. In vitro antiproliferative activity of docetaxel (Taxotere), paclitaxel (Taxol) and cisplatin against human tumour and normal bone marrow cells.
Braakhuis BJ; Hill BT; Dietel M; Kelland LR; Aapro MS; Zoli W; Lelieveld P
Anticancer Res; 1994; 14(1A):205-8. PubMed ID: 7909419
[TBL] [Abstract][Full Text] [Related]
33. Differential sensitivity to paclitaxel-induced apoptosis and growth suppression in paclitaxel-resistant cell lines established from HEC-1 human endometrial adenocarcinoma cells.
Tanaka T; Toujima S; Tanaka J
Int J Oncol; 2012 Nov; 41(5):1837-44. PubMed ID: 22923148
[TBL] [Abstract][Full Text] [Related]
34. In vitro sensitivity of human endometrial cancer cell lines to paclitaxel or irinotecan (CPT-11) in combination with other aniticancer drugs.
Hiramatsu HP; Kikuchi Y; Seto H; Nagata I
Anticancer Drugs; 2000 Aug; 11(7):573-8. PubMed ID: 11036961
[TBL] [Abstract][Full Text] [Related]
35. Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.
Kelland LR; Abel G
Cancer Chemother Pharmacol; 1992; 30(6):444-50. PubMed ID: 1356649
[TBL] [Abstract][Full Text] [Related]
36. Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines.
Gentilin E; Minoia M; Bondanelli M; Tagliati F; Degli Uberti EC; Zatelli MC
Endocrine; 2017 Jun; 56(3):621-632. PubMed ID: 27585662
[TBL] [Abstract][Full Text] [Related]
37. [Antitumor effect of docetaxel against human endometrial tumor cell lines].
Shakuto S; Noguchi K; Bissery MC
Gan To Kagaku Ryoho; 2005 Oct; 32(10):1437-42. PubMed ID: 16227744
[TBL] [Abstract][Full Text] [Related]
38. The steroidogenic and morphological effects of paclitaxel on cultured ovarian cancer cells.
Cameron MR; Caudle MR; Sullivan WR; Peluso JJ; Wimalasena J
Oncol Res; 1995; 7(3-4):145-56. PubMed ID: 8555648
[TBL] [Abstract][Full Text] [Related]
39. Paclitaxel, Carboplatin and 1,25-D3 Inhibit Proliferation of Endometrial Cancer Cells
Kuittinen T; Rovio P; Staff S; Luukkaala T; Kallioniemi A; Grénman S; Laurila M; Mäenpää J
Anticancer Res; 2017 Dec; 37(12):6575-6581. PubMed ID: 29187432
[TBL] [Abstract][Full Text] [Related]
40. Comparison of in vitro methods for assessing cytotoxic activity against two pancreatic adenocarcinoma cell lines.
Chang BK
Cancer Res; 1983 Jul; 43(7):3147-9. PubMed ID: 6850624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
